Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Jan 2020 - Dec 2020
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
3
Lobbying Costs over the years
-
Info
Tuberculosis Vaccine Initiative (TBVI)
EU Transparency Register
194671518391-54 First registered on 31 Jul 2015
Goals / Remit
To support, integrate, translate and prioritise R&D efforts to discover and develop new tuberculosis vaccines that are accessible and affordable for all.
Main EU files targeted
Work has finalized under the Horizon2020 program via a consortium agreement for which TBVI is the coordinator. New funding is required for continuous research.
Address
Head Office
Runderweg 6
Lelystad 8219 pk
NETHERLANDSEU Office
Runderweg 6
Lelystad 8219 pk
NETHERLANDSWebsite
-
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
Person active in a.o. resource mobilization
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
None declared
Member organisations
None declared
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Jan 2020 - Dec 2020
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
1,150,441€
Major funding types in closed year
Public financing, EU funding
Major contributions in closed year
Type Name Amount Contribution European Union 90,439€ Contribution Trustees 50,095€ Contribution CDMRP 50,887€ Contribution EDCTP 352,001€ Contribution VWS/ADITEC 252,440€ Contribution bmgf 410,801€ Contribution STRiTuVaD 34,217€ Grant European Union 90,439€ Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
TBVAC
NewTBVAC
TBVAC2020Other activities
None declared
Meetings
Meetings
3 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 18 Sep 2018 Location Brussels Subject TB, UN high level meeting on TB Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Alina Timofte (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
-
Date 17 Oct 2016 Location Brussels, Belgium Subject TB Vaccine R&D and H2020 programme DG Research and Innovation Attending - Robert-Jan Smits (Director-General)
-
Date 16 Jul 2015 Location Brussels Subject Presentation of TBVI activities Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Carlos Moedas (Commissioner)